Swiss National Bank
AGIO icon

Swiss National Bank’s Agios Pharmaceuticals AGIO Stock Holding History

Swiss National Bank’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.14M Buy
111,660
+2,800
+3% +$84.9K ﹤0.01% 1549
2026
Q1 		$3.68M Hold
108,860
– – ﹤0.01% 1520
2025
Q4 		$2.96M Buy
108,860
+2,200
+2% +$77.2K ﹤0.01% 1657
2025
Q3 		$4.28M Sell
106,660
-2,800
-3% -$105K ﹤0.01% 1411
2025
Q2 		$3.64M Buy
109,460
+10,000
+10% +$303K ﹤0.01% 1455
2025
Q1 		$2.91M Sell
99,460
-1,300
-1% -$43.1K ﹤0.01% 1556
2024
Q4 		$3.31M Buy
100,760
+1,000
+1% +$47K ﹤0.01% 1550
2024
Q3 		$4.43M Buy
99,760
+300
+0.3% +$13.6K ﹤0.01% 1403
2024
Q2 		$4.29M Sell
99,460
-10,400
-9% -$375K ﹤0.01% 1366
2024
Q1 		$3.21M Hold
109,860
– – ﹤0.01% 1573
2023
Q4 		$2.45M Sell
109,860
-12,300
-10% -$276K ﹤0.01% 1722
2023
Q3 		$3.02M Buy
122,160
+1,800
+1% +$47.6K ﹤0.01% 1583
2023
Q2 		$3.41M Buy
120,360
+13,700
+13% +$341K ﹤0.01% 1546
2023
Q1 		$2.45M Sell
106,660
-12,400
-10% -$329K ﹤0.01% 1711
2022
Q4 		$3.34M Buy
119,060
+2,100
+2% +$59.2K ﹤0.01% 1560
2022
Q3 		$3.31M Buy
116,960
+1,400
+1% +$37.6K ﹤0.01% 1535
2022
Q2 		$2.56M Hold
115,560
– – ﹤0.01% 1744
2022
Q1 		$3.36M Sell
115,560
-1,200
-1% -$36.7K ﹤0.01% 1709
2021
Q4 		$3.84M Sell
116,760
-5,700
-5% -$229K ﹤0.01% 1639
2021
Q3 		$5.65M Sell
122,460
-15,600
-11% -$754K ﹤0.01% 1374
2021
Q2 		$7.61M Sell
138,060
-4,300
-3% -$240K ﹤0.01% 1192
2021
Q1 		$7.35M Buy
142,360
+1,800
+1% +$89.1K ﹤0.01% 1204
2020
Q4 		$6.09M Hold
140,560
– – ﹤0.01% 1243
2020
Q3 		$4.92M Buy
140,560
+2,900
+2% +$127K ﹤0.01% 1181
2020
Q2 		$7.36M Buy
137,660
+20,700
+18% +$958K 0.01% 933
2020
Q1 		$4.15M Buy
116,960
+1,500
+1% +$69.3K ﹤0.01% 1030
2019
Q4 		$5.51M Buy
115,460
+16,000
+16% +$605K 0.01% 1091
2019
Q3 		$3.22M Buy
99,460
+1,700
+2% +$70.4K ﹤0.01% 1377
2019
Q2 		$4.88M Buy
97,760
+2,400
+3% +$128K 0.01% 1137
2019
Q1 		$6.43M Buy
95,360
+3,100
+3% +$181K 0.01% 937
2018
Q4 		$4.25M Buy
92,260
+2,500
+3% +$154K 0.01% 1078
2018
Q3 		$6.92M Hold
89,760
– – 0.01% 896
2018
Q2 		$7.56M Buy
89,760
+2,700
+3% +$235K 0.01% 847
2018
Q1 		$7.12M Buy
87,060
+17,000
+24% +$1.31M 0.01% 856
2017
Q4 		$4M Buy
70,060
+1,600
+2% +$101K ﹤0.01% 1201
2017
Q3 		$4.57M Buy
68,460
+2,200
+3% +$132K 0.01% 1074
2017
Q2 		$3.41M Buy
66,260
+10,900
+20% +$557K ﹤0.01% 1238
2017
Q1 		$3.23M Buy
55,360
+1,800
+3% +$86.3K ﹤0.01% 1266
2016
Q4 		$2.23M Hold
53,560
– – ﹤0.01% 1479
2016
Q3 		$2.83M Buy
53,560
+6,000
+13% +$261K ﹤0.01% 1287
2016
Q2 		$1.99M Buy
47,560
+10,800
+29% +$533K ﹤0.01% 1509
2016
Q1 		$1.44M Buy
36,760
+7,700
+26% +$329K ﹤0.01% 1656
2015
Q4 		$1.89M Hold
29,060
– – ﹤0.01% 1384
2015
Q3 		$2.05M Buy
29,060
+3,800
+15% +$371K 0.01% 1289
2015
Q2 		$2.81M Buy
25,260
+900
+4% +$96.9K 0.01% 1112
2015
Q1 		$2.3M Hold
24,360
– – 0.01% 1199
2014
Q4 		$2.73M Buy
24,360
+8,960
+58% +$800K 0.01% 1067
2014
Q3 		$945K Hold
15,400
– – ﹤0.01% 1699
2014
Q2 		$706K Buy
15,400
+9,100
+144% +$371K ﹤0.01% 1935
2014
Q1 		$247K Buy
6,300
+1,600
+34% +$53.5K ﹤0.01% 2390
2013
Q4 		$113K Buy
+4,700
New +$107K ﹤0.01% 2468

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Swiss National Bank's AGIO Position: Q2 2026 in Review

Swiss National Bank increased its Agios Pharmaceuticals (AGIO) stake by 2.6% in Q2 2026, buying an estimated $84.9K and bringing the position to 111,660 shares worth $4.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1549.

Swiss National Bank first reported a position in AGIO in Q4 2013 and has held it in 51 quarters since. The position peaked at $7.61M in Q2 2021. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Swiss National Bank held 111,660 shares of Agios Pharmaceuticals worth $4.14M as of Q2 2026.
  • Swiss National Bank bought 2,800 Agios Pharmaceuticals shares in Q2 2026, an estimated $84.9K.
  • Agios Pharmaceuticals made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1549 holding.
  • Swiss National Bank first reported a position in Agios Pharmaceuticals in Q4 2013 and has held it in 51 quarters since.
  • Swiss National Bank's Agios Pharmaceuticals position peaked at $7.61M in Q2 2021.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.